Brisbane biotech secures $14 mn for drug discovery
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2013
Singapore: The University of Queensland-based biotechnology company Protagonist Therapeutics has secured $14 million in ...Read more
AdiStem platelet rich plasma to cure joint pain
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2012
Singapore: AdiStem, a provider of photo activation technology and medical solutions, highlighted that platelet rich pla...Read more
Patent duration too short in Australia: AusBiotech
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 29 Jan, 2013
Singapore: AusBiotech, the bioscience industry organization of Australia, has told the government that patent length in ...Read more
Helmedix: Using helminthes to treat autoimmune diseases
Australia | Influencers | By BioSpectrum Bureau | 2 Comment | 11 Mar, 2013
Valentine's Day, which is marked as a day to commemorate the death anniversary of Saint Valentine, saw the birth of a ve...Read more
NZ firm migrates to Aus to capitalize on MS drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2013
Singapore: New Zealand-based biopharmaceutical company Innate Immunotherapeutics is migrating to Australia in a move to ...Read more
Dr Anna Lavelle gets ATSE fellowship
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 21 Oct, 2014
Singapore: Dr Anna Lavelle, CEO, AusBiotech, has been elected to Fellowship of the Australian Academy of Technological S...Read more
Admedus increases share in Ian Frazer vaccine tech
Australia | News | By BioSpectrum Bureau | 2 Comment | 24 Jul, 2014
Singapore: Australia's healthcare company focused on investing in and developing next generation technologies, Admedus, ...Read more
Top 20: AUSTRALIA - Achieves marginal growth
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 07 Jul, 2014
With 11 percent share and $11.65 billion is revenue, Australia grew marginally. It has been a bad year or Australia's...Read more
Mayne Pharma to buy Doryx from Actavis
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2015
Singapore: Australia-based Mayne Pharma has struck a deal to acquire Doryx acne-treatment brand and assets in the US for...Read more
Australia's Orthocell gets Chinese patent for scaffold technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2015
Singapore: Australia's regenerative medicine company, Orthocell, has recieved Chinese patent for its Collagen Scaffold f...Read more
SII seeks WHO consent to export flu vaccines
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2012
Singapore: Serum Institute of India (SII) has applied for permits to export flu vaccines produced using Australia's BioD...Read more
QRxPharma refiles Moxduo NDA with FDA
Australia | News | By BioSpectrum Bureau | 0 Comment | 26 Nov, 2013
Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...Read more
Japan's NEC to exploit Prima BioMed's cancer immunotherapeutic technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 May, 2015
The press release indicated that Immutep is a French company and is a 100 percent subsidiary of Prima BioMed. Immutep de...Read more
Phosphagenics to start opioid pain patch study
Australia | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2012
Singapore: Melbourne-based Phosphagenics has resolved all crystallisation issues associated with its opioid patch devel...Read more
Australia to finalize a policy on naming biosimilars
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Jan, 2015
Singapore: In July 2013, Therapeutics Goods Administration, Australia, had published a guidance on biosimlar naming base...Read more
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2015
Singapore: Australia based Novotech has strengthened its Hong Kong operation with expansion of its manpower base. The c...Read more
Bridge to the DNA vaccine dream
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
Can DNA vaccines be the answer to diseases such as malaria and influenza? Though DNA-based vaccines have emerged as appe...Read more
AirStrip enters the Australian market
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2015
Singapore: US-based AirStrip recently inked a pact with Life Monitor, a subsidiary of Cardioscan, to sell AirStrip solut...Read more